Journal Finder

Postepy Higieny i Medycyny Doswiadczalnej (Advances in Hygiene and Experimental Medicine) publishes reviews and original papers from the field of medicine and related sciences, with particular regard to immunology, microbiology, and genetics. Review papers should have the character of critical reviews pertaining to the given field. Articles submitted for publication may not have been previously published in printed or electronic form, neither in whole nor in part. Papers which qualify for publication shall become the property of Postepy Higieny i Medycyny Doswiadczalnej, to which the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wroclaw (Instytut Immunologii i Terapii Doswiadczalnej PAN we Wroclawiu) has legal right. .

Prion is the first international peer-reviewed journal to focus exclusively on protein folding and misfolding, protein assembly disorders, protein-based and structural inheritance. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The overriding criteria for publication in Prion are originality, scientific merit and general interest.Prion is a quarterly publication. Accepted manuscripts will be made available on the website immediately.

Conference proceedings are accepted for publication in Procedia in Vaccinology based on suitability and are required to meet certain criteria, including relevance to an international audience and covering highly cited or timely topics. Procedia in Vaccinology will cover proceedings in all topics related to vaccines and vaccination.

What does Procedia in Vaccinology offer authors and conferences organizers?
Procedia in Vaccinology offers a single, highly recognized platform where conference papers can be hosted and accessed by millions of researchers. Authors then know where to go to keep abreast of the latest developments in their field. All proceedings appear online, on Science Direct, within 8 weeks of acceptance of the final manuscripts via the conference organizer and are freely available to all users. Procedia in Vaccinology offers authors and conference organizers a fast and cost effective way to provide maximum exposure for their papers.

Word templates are provided to assist in the publication and the final online papers contain linked references, XML versions and DOI numbers.

Why should conference organizers choose Procedia in Vaccinology?
Unlike regular journals, there is no limit to the amount of papers a Procedia in Vaccinology issue can contain and pricing is affordable, clear and transparent. Procedia in Vaccinology offers immediate access for all, with papers online within 8 weeks of acceptance, and free access providing maximum exposure for individual papers and the related conference. Organizers are credited on the actual issue and are fully responsible for quality control, the review process and the content of individual conference papers.

What is the process for submitting conference proceedings to Procedia in Vaccinology?
Proposals, including a synopsis of why such a Procedia in Vaccinology issue will have an impact on its community, a list of agreed contributors and an outline of the related conference (including a link to the conference website) should be sent to:

Alina Helsloot
Executive Publisher
a.helsloot@elsevier.com

Proposals should be prepared using the template /inca/publications/misc/PROVAC Proposal Template.dochere.

Please note that we do not accept proposals from individual authors for Procedia titles.

What are the costs associated with Procedia in Vaccinology?
There is an agreed fee, based on the size of the proceedings, which includes online publication on http://www.sciencedirect.comScienceDirect and free access after acceptance. In addition to the online version there is the possibility to purchase paper copies, CD-ROMs and USB sticks. Moreover, interactive media possibilities such as webcasts and web seminars can be acquired for extra exposure both before and after the conference.

Can Procedia in Vaccinology be sponsored?
We are open to discussing sponsoring possibilities at all times. Sponsors can include funding bodies, government agencies and/or industry. Benefits to sponsors include visibility amongst a scientific audience and the opportunity to communicate messages via a peer-reviewed platform. Benefits to authors and conference organizers are the further dissemination of material to an international audience and reduced costs to the overall conference budget.

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.

Recent Patents on Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery.

Retrovirology is a stringently peer-reviewed journal edited by Kuan-Teh Jeang (USA), Monsef Benkirane (France), Ben Berkhout (the Netherlands), Masahiro Fujii (Japan), Ariberto Fassati (UK), Michael Lairmore (USA), Andrew Lever (UK), and Mark Wainberg (Canada) with the assistance of an internationally renowned Editorial Board.

Virologists are acquisitive investigators who wish to apply the latest scientific developments to their own work. The aim of Reviews in Medical Virology is therefore to provide them with articles reviewing conceptual or technological advances in diverse areas of virology. Topics covered will include the molecular biology, cell biology, replication, pathogenesis, immunology, immunization, epidemiology, diagnosis or treatment of viruses of medical importance.

REVISTA IBEROAMERICANA DE MICOLOGÍA (IberoAmerican Journal of Mycology), the official journal of the Spanish, Venezuelan and Argentinean Mycology Associations (Asociación Española de Micología, Asociación Venezolana de Micología and Asociación Argentina de Micología), considers for publication, original articles, reviews, Mycology Forum, editorials, special articles, notes, and letters to the editor. All scientific contributions will be subject to an external anonymous peer review process. Articles published in REVISTA IBEROAMERICANA DE MICOLOGÍA are abstracted and indexed in Biological Abstracts, Chemical Abstracts, Current Contents/ISI Web of Science, Excerpta Medica, Índice Médico Español (Spanish Medical Index), Index Medicus/Medline/Pub-Med, Scirus and SCOPUS.

To publish scientific papers related to infectious and parasitic diseases, preventive medicine, public health and related subjects.

To publish articles dealing with research on different aspects of tropical infectious diseases, provided that data and results are directly linked to human health.

SAHARA-J is an international Open Access journal disseminating vital research on social factors relating to HIV/AIDS. Areas covered include care, support, behaviour change, behavioural surveillance, counselling, impact, mitigation, stigma, discrimination, prevention, treatment, adherence, culture, faith-based approaches, evidence-based intervention, health communication, structural and environmental intervention, financing, policy, media and more. SAHARA-J publishes peer-reviewed contributions of the highest quality from researchers in Sub-Saharan Africa and other developing countries around the world. SAHARA J has a unique reputation for editorial excellence and integrity, who maintain an active interest in all aspects of HIV/AIDS. The readership of the Journal varies from academics, scholars to researchers. Internet users such as Journalists, international organizations, policy makers, civil society, donors and PLWHA also have free access to the Journal. SAHARA-J ensures that policy makers are well informed, help coordinate social aspects of HIV/AIDS research, minimizes duplication and build the community of social aspects of HIV/AIDS researchers. Its objectives are: • To influence policy and responses through the production and dissemination of evidence-based research on social aspects of HIV/AIDS. • To provide a publication source for all aspects of HIV/AIDS in Africa. • To disseminate free HIV/AIDS information in Africa. The journal is published by Routledge on behalf of SAHARA, the Social Aspects of HIV/AIDS Research Alliance, which is part of the Human Sciences Research Council (HSRC). SAHARA is an alliance of partners established to conduct, support and use social sciences research to prevent the further spread of HIV and mitigate the impact of its devastation in sub-Saharan Africa. .

Scandinavian Journal of Infectious Diseases publishes original papers on clinical aspects of infectious diseases. The topics may concern clinical aspects of infectious diseases, laboratory investigations of clinical significance (bacteriological, virological, parasitological, mycological, immunological, pathological, physiological, chemical and pharmacological), epidemiological and epizootological studies of human infections and experimental infections. Manuscripts are welcomed both from Scandinavian and other countries. In addition to regular articles, review articles, case reports, short communications and letters may be accepted. The journal was started in 1969 and was the first European journal in English entirely devoted to the clinical and microbiological aspects of infectious diseases. Read More: http://informahealthcare.com/page/inf/Description.

Sexual Health publishes original and significant contributions to the fields of sexual health including HIV/AIDS, Sexually transmissible infections, issues of sexuality and relevant areas of reproductive health. This journal is directed towards those working in sexual health as clinicians, public health practitioners, researchers in behavioural, clinical, laboratory, public health or social, sciences. The journal publishes peer reviewed original research, editorials, review articles, topical debates, case reports and critical correspondence. Authors interested in preparing a feature article, a mini-review or a viewpoint article are invited to discuss the matter with the Editor.

Sexually Transmitted Diseases, the official journal of the American Sexually Transmitted Diseases Association, publishes peer-reviewed, original articles on clinical, laboratory, immunologic, epidemiologic, behavioral, public health, and historical topics pertaining to sexually transmitted diseases and related fields. Reports from the CDC and NIH provide up-to-the-minute information. A highly respected editorial board is composed of prominent scientists who are leaders in this rapidly changing field. Included in each issue are studies and developments from around the world.Journal articles posted prior to 12 months of current issue is freely accessible.Indexed/abstracted in: MEDLINE/PUBMED, EMBASE, SCOPUS, International Pharmaceutical Abstracts (IPA), BIOSIS Previews, Science Citation Index Expanded, Current Contents/Clinical Medicine and Life Sciences, Chemical Abstracts.

Sexually Transmitted Infections is the world's longest running international journal on sexual health. It aims to keep practitioners, trainees and researchers up to date in the prevention, diagnosis and treatment of all STIs and HIV. The journal publishes original research, evidence based reviews and comment on the clinical, epidemiological, sociological and laboratory aspects of sexual health from around the world. We also publish educational articles, letters and other material of interest to readers, along with podcasts and other online material. STI provides a high quality editorial service from submission to publication.